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Objectives The purpose of this study was to evaluate the antiarrhythmic potential of mesenchymal stem cells (MSC) under
a different environment.
Background Little is known about how environmental status affects antiarrhythmic potential of MSCs.
Methods To investigate the effect of paracrine factors secreted from MSCs under different circumstances on arrhythmogenicity
in rats with myocardial infarction, we injected paracrine media (PM) secreted under hypoxic, normoxic conditions (hy-
poxic PM and normoxic PM), and MSC into the border zone of infarcted myocardium in rats.
Results We found that the injection of hypoxic PM, but not normoxic PM, markedly restored conduction velocities, sup-
pressed focal activity, and prevented sudden arrhythmic deaths in rats. Underlying this electrophysiological alter-
ation was a decrease in fibrosis, restoration of connexin 43, alleviation of Ca2 overload, and recovery of Ca2-
regulatory ion channels and proteins, all of which is supported by proteomic data showing that several paracrine
factors including basic fibroblast growth factor, insulinlike growth factor 1, hepatocyte growth factor, and EF-
hand domain-containing 2 are potential mediators. When compared with PM, MSC injection did not reduce or
prevent arrhythmogenicity, suggesting that the antiarrhythmic or proarrhythmic potential of MSC is mainly de-
pendent on paracrine factors.
Conclusions A hypoxic or normoxic environment surrounding MSC affects the type and properties of the growth factors or
cytokines, and these secreted molecules determine the characteristics of the electro-anatomical substrate
of the surrounding myocardium. (J Am Coll Cardiol 2012;60:1698–706) © 2012 by the American College
of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.04.056Advances in stem cell biology provide a basis for potential
cell therapy to cure myocardial infarction (MI). In spite of
early success reports, there are inconsistencies regarding the
therapeutic benefits of mesenchymal stem cells (MSC)–
based therapy for MI (1). Cellular heterogeneities caused by
stem cell injection may increase arrhythmogenesis (2,3), and
growth factors and cytokines released from transplanted
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has emerged as a promising option to repair impaired
contractile function, confounding issues concerning the
proarrhythmic and antiarrhythmic potentials of stem cell
therapy have led to intense discussion.
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October 23, 2012:1698–706 Antiarrhythmic Potential of Paracrine FactorsThe proarrhythmic potentials by MSC can be attributed to
tissue heterogeneity by transplantation of unexcitable MSC (2),
ossible heterogeneous sympathetic nerve sprouting (6), teratoma
ormation, and spontaneous focal activity. The inconsistent results
ay be due to varying circumstances surrounding implantation
ites. However, little is known about how environmental status
ffects the potential role of stem cells, particularly with respect to
heir ability to prevent arrhythmogenicity.
This investigation focused on whether paracrine factors
eleased from MSC could modulate the electrophysiological
roperties of the border or ischemic zone, creating spontaneous
ocal activity through impaired intracellular calcium handling
7,8) or reentrant arrhythmia (9). The present study also
ought to evaluate the direct effect of MSC by comparing
SC-engrafted rats with rats treated only with paracrine factors.
e found that MSC produced beneficial antiarrhythmic para-
rine factors under the hypoxic condition, providing new insights
or potential role of environment to activate stem cells.
ethods
reparation of paracrine media. Paracrine media (PM)
as prepared as follows: 90% confluent second passage
SC were fed with serum-free Dulbecco Modified Eagle
edium. MSC (1  106cells) were cultured for 12 h under
ypoxia or normoxia. The media of MSC cultured under
ypoxia was defined as hypoxic PM and media cultured
nder normoxia as normoxic PM, and both were assumed to
ontain various paracrine molecules. Hypoxic PM and
ormoxic PM were collected. Hypoxic conditions were
reated by incubating cells at 37°C in an anaerobic system
Technomart Inc., Seoul, South Korea) with a 5% CO2, 5%
H2, and 85% N2 atmosphere, and a chamber oxygen level of
0.5%. A colorimetric redox indicator solution (resazurin, 89%,
Sigma-Aldrich, St. Louis, Missouri) was used to ensure that
hypoxic conditions were maintained. For injection, conditioned
medium from 1 106 cells was centrifuged to remove cell debris
and concentrated by VIVASPIN6 (Vivascience Ltd., Scottsdale,
Arizona). The medium was continuously centrifuged a 1,000 g
for 30 min at 4°C using an ultracentrifuge.
MI induction and treatment of hypoxic PM, normoxic
PM, and MSC. All animal experimental procedures were
approved by the Committee for Care and Use of Laboratory
Animals, Yonsei University College of Medicine, and per-
formed in accordance with the Guidelines and Regulations
for Animal Care. MI was produced in male Sprague-
Dawley rats (250 to 300 g) by left anterior descending
coronary artery ligation, as described. Briefly, after anesthe-
sia with ketamine (100 mg/kg) and xylazine (5 mg/kg),
hearts were exteriorized by opening the chest at the third
and fourth ribs. After 1 h of occlusion, the infarcted heart
was reperfused and sham (saline), hypoxic PM, normoxic
PM, or MSC were injected at the border region. Hypoxic
PM or normoxic PM of MSC (1 106 cells) was enriched to
100 l and injected into the infarct border region in 3 different
sites using a syringe with a 30-gauge needle. For MSCtransplantation, cells (1  106
cells) were suspended in 10 l of
serum-free medium and injected
into the border in the same way.
Rats that expired during the pro-
cedure or immediately after cell
implantation were excluded for
sudden death mortality. For iden-
tification of arrhythmic death as
the cause of death, rats were mon-
itored by telemetry (Online Fig. 1)
and autopsies were performed with
these rats to confirm that the ani-
mals did not expire from cardiac
rupture. Experimental groups were
used for surface electrocardiogra-
phy, telemetric monitoring, in vivo
isoproterenol test, optical map-
ping, Millar catheterization, and
morphologic analysis at 11 days
after injection of hypoxic PM,
normoxic PM, or MSC.
Optical mapping. For optical
mapping, hearts were excised,
retrogradely perfused through
the aorta with Tyrode solution,
gassed with 95% O2 and 5%
O2, and stained with a voltage sensitive dye, di-4-
ANEPPS (Invitrogen Corporation, Carlsbad, California).
Hearts were placed in a chamber to maintain 37.0  0.2°C,
and 5 mol/l blebbistatin was added to the perfusate to
educe movement artifacts. Excitation light was delivered by
pi-illumination with 2 green light-emitting diode lamps
500  30 nm, LL-50R30-G25, Optronix, Seoul, Korea).
luorescence images from the anterior surface of the heart
ere recorded with a charge-coupled device camera (128 
28 pixels, Dalsa Inc., Billerica, Massachusetts) and the
eld of view was 1.0  1.0 cm2 with a spatial resolution of
8  78 m2. The sampling rate was 420 frames/s. The
rhythm of optical recordings was continuously monitored by
electrocardiograms obtained with widely spaced bipoles, 1 at
the apex of the left ventricle and the other at the high lateral
wall of the right ventricle, using a Biopac System (BIOPAC
Systems Inc., Goleta, California). Fluorescence recordings
were filtered with a Gaussian filter (3  3 pixels) in the
spatial domain, and first-order derivatives (dF/dt) were
calculated using a polynomial filter (third order, 13 points)
in the temporal domain. Activation time points at each site
were determined from (dF/dt)max, and isochronal maps of
ctivation were generated. The duration of the action
otential at 80% repolarization (APD80) was measured.
Conduction velocity (CV) within the border or normal
regions was measured under point stimulation at a cycle
length of 280 ms for 20 beats. Local CV vectors were
estimated from each pixel’s 7 nearest neighbors in the activa-
Abbreviations
and Acronyms
APD80  duration of the
action potential at 80%
repolarization
bFGF  basic fibroblast
growth factor
CV  conduction velocity
Cx43  connexin 43
HGF  hepatocyte growth
factor
IGF  insulinlike growth
factor
LTCC  L-type calcium
channel
MI  myocardial infarction
mRNA  messenger
ribonucleic acid
MSC  mesenchymal stem
cell(s)
PM  paracrine media
PVC  premature
ventricular contraction(s)
VT  ventricular
tachyarrhythmiation time of its temporal wave. To improve the signal-to-noise
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Antiarrhythmic Potential of Paracrine Factors October 23, 2012:1698–706ratio, the local CV was spatially filtered using a 7  7
nearest-neighbor Gaussian convolution kernel and the acute
change in its magnitude was suppressed using log-
transformation (10,11). A CV map of the anterior surface of
the heart focused by charge-coupled device camera was
derived from local CV. Border zones were identified from
activation map where slow conduction occurred. Infarct
zones were defined as the area where the voltage signals
were near completely absent. Analyses were performed with
software using IDL (version 6.4, Research Systems, Boul-
der, Colorado) and MATLAB (Mathworks, Inc., Natick,
Massachusetts).
Statistical analysis. Data are expressed as mean  SE for
continuous variables and as proportions for categorical
variables. Statistical analyses of more than 2 groups were
done by 1-way analysis of variance for parametric variables.
Bonferroni adjustment was used for multiple comparisons.
Premature ventricular contractions (PVC) and CV with
nonparametric distribution were analyzed by the Kruskal-
Wallis test followed by post hoc testing via Mann-Whitney
U test with Bonferroni adjustment for multiple testing. The
chi-square test or the Fisher exact test for categorical
variables was used. Survival was analyzed by the Kaplan-
Meier method with the Breslow test. A p value of 0.05
was considered statistically significant. The SPSS statistical
package (version 18.0, SPSS Inc., Chicago, Illinois) was
used. Details were described in Online Appendix.
Cell culture, in vivo, and in vitro analyses. These meth-
ods are provided in detail in the Online Appendix.
Results
Paracrine factors from MSC under hypoxic condition
prevent sudden death in infarcted rats. The risk of
sudden death is highest in the early phase of MI (12), so we
evaluated survival rates over 11 days after injury and treat-
ment of sham (n  23), PM secreted from MSC under
ypoxia (hypoxic PM group; n  22), PM secreted under
ormoxia (normoxic PM group; n  23), and MSC (n 
2). As shown in Figure 1A, Kaplan-Meier survival curves
evealed a marked reduction in sudden deaths in hypoxic
M–treated rats compared with sham-injected rats (13% in
ypoxic PM group vs. 57% in sham group, p  0.01) or
ormoxic PM–treated rats (13% in hypoxic PM group vs.
9% in normoxic PM group, p  0.05). This finding
uggests that paracrine factors secreted from MSC might
ave different protective effects, especially with respect to
rrhythmogenicity, depending on their environment. MSC-
ransplanted (32%, n  22) or normoxic PM–treated rats
39%, n  23) showed a slight decrease of death, but not
ignificant, compared with sham-injected rats (p  0.05).
ypoxic PM enhances electrical stability. We studied
nimals using left ventricular catheterization (Online
able 1), electrocardiogram (Online Table 2), or telemetric
onitoring. We found improved left ventricular contractileunction and shorter QRS duration in hypoxic PM–treated Pats than in sham-injected rats. In addition, PVC tended to
e suppressed by hypoxic PM treatment (Online Fig. 2).
e further examined the protective effect of paracrine
actors with isoproterenol infusion, which facilitates both
arly afterdepolarization and delayed afterdepolarization
13). For 15 min after intraperitoneal injection of isopro-
erenol (2 mg/kg), sustained ventricular tachyarrhythmia
VT) was induced in 1 of 9 sham-injected rats, but not in
he hypoxic PM–, normoxic PM–, and MSC-treated rats.
requent PVC were induced in the sham-injected animal
roup, whereas PVC were significantly reduced in hypoxic
M–treated rats (Figs. 1B and 1C).
To further investigate vulnerability to arrhythmias of
nfarcted hearts injected with paracrine factors, we per-
ormed an ex vivo electrical vulnerability test using a
urst-pacing protocol. No monomorphic or polymorphic
T was observed in noninfarcted control rats (n  10).
owever, VT were induced in 81.8% of sham-injected rats
n  11), indicating that localized MI markedly enhances
nduction of VT, allowing a systematic evaluation of how
M secreted from MSC affects electrical vulnerability. VT
ccurred in 16.7% of 12 hypoxic PM–treated rats (sham vs.
ypoxic PM, p  0.01), in 58.3% of 12 normoxic PM–
reated rats (normoxic PM vs. hypoxic PM, p  0.05), in
6.7% of 15 MSC-treated rats (MSCs vs. hypoxic or
ormoxic PM, p  0.05) (Fig. 1D). VT vulnerability score
as also different between hypoxic- and normoxic-PM
reatments, data not shown. In an analysis of covariance
djusted for left ventricular ejection fraction, the strong
ssociation between VT vulnerability and PM treatments
as noted (Online Fig. 3). This supplied evidence of a
ignificant difference of antiarrhythmic role of PMs secreted
rom different environments.
ypoxic PM improves conduction through border
one. We assessed the electrophysiological impact of para-
rine factors on the infarcted myocardium by optical map-
ing using Langendorff perfusion at 7 to 11 days after injury
nd treatment. Wave propagation in sham-injected hearts
as prominently blocked at the boundaries of the infarcted
egions (Online Fig. 4). In contrast, action potentials
nitially circumventing the infarct region propagated trans-
urally in hypoxic PM–treated hearts (Online Fig. 4). Focal
ctivity arising from the infarct border is a representative
lectrophysiological feature that triggers arrhythmia in MI
7,8). Spontaneous ectopic beats emanating from the border
egion at sinus rhythm were observed frequently in 55.6% of
ham-injected rats (n  9) (Fig. 2A). However, treatment
ith hypoxic PM markedly suppressed the ectopic focal
eats from the border region (0%, n  6), with normoxic
M treatment (33.3%, n  6) resulting in moderate
uppression. In MSC-treated hearts, the ectopic focal beats
ere also moderately suppressed (25%, n  8), to similar
xtent compared with the beats of normoxic PM–treated
earts. Local CV was markedly depressed in the border
one of sham-injected hearts and moderately in normoxic
M–treated border, in contrast to the notable restoration of
1701JACC Vol. 60, No. 17, 2012 Hwang et al.
October 23, 2012:1698–706 Antiarrhythmic Potential of Paracrine FactorsCV seen in hypoxic PM–treated hearts (Fig. 2B). Figure 2C
presents the different regional distributions of CV in hypoxic
PM- and normoxic PM–treated hearts. CV was also moder-
ately restored in MSC-treated border zone to a similar extent
compared with normoxic PM–treatment (Fig. 2B). In con-
trast, APD80 was significantly different between the MSC-
transplanted border zones and normoxic PM–treated border
zones (Fig. 2D, Online Fig. 5). To identify the electrophysi-
ological alteration due to MSC implantation, we confirmed the
presence of 4=,6-diamidino-2-phenylindole–labeled MSC at
the injected sites (Fig. 2D).
Hypoxic PM restores conduction by a decrease in fibrosis
and recovery of connexin 43. This series of experiments
proposes that the enhanced conduction resulting from
treatment with hypoxic PM could be attributed to the
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Figure 1 Improvement of Survival and VT Protection by Hypoxic
(A) Incidence of sudden death for sham-injected animal (n  23), hypoxic paracrin
injected rats (n  22) during the 11 days after injury and treatment. Survival was
mature ventricular contractions (PVC) from an in vivo isoproterenol test (*p  0.0
surface electrocardiogram recording from an in vivo isoproterenol test. Sustained
rarely observed in hypoxic PM–injected rats (middle, I) and frequent PVC were not
Note strongly reduced susceptibility to VT induction in PM-injected groups compare
normoxic PM– and MSC-injected rats (**p  0.005). Numbers above bars indicatrescue of hypoxic cardiomyocytes from apoptosis and thesubsequent decrease in fibrous tissue (14), which caused
slow conduction by a zigzag course of activation, thus
facilitating reentry (9). Deoxyuride-5=-triphosphate biotin
nick end labeling–positive myocardial cells were signifi-
cantly reduced by approximately 50% in hypoxic PM–
treated hearts compared with sham-injected hearts
(Fig. 3A). Fibrosis was significantly decreased in hypoxic
PM–treated hearts and not noticeably decreased in nor-
moxic PM–treated hearts (Fig. 3B). The degree of fibrosis
in MSC-transplanted rats was similar to that in normoxic
PM–treated rats (15.1  2% in MSC-transplanted hearts
vs. 15.3  1.5% in normoxic PM–treated hearts, p  0.05),
implicating that the effects of paracrine action of MSC in
this model might be similar to the effects of normoxic PM.
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Antiarrhythmic Potential of Paracrine Factors October 23, 2012:1698–706nexin 43 (Cx43) signal in the border zone of a post-infarct
heart was decreased and was not in the intercalated disk area,
and dephosphorylated Cx43 was increased. Hypoxic PM
ameliorated dramatically the distribution of total Cx43,
whereas the disarray of Cx43 was partially restored by nor-
moxic PM or MSC injection (Fig. 3C). Moreover, dephos-
phorylated Cx43 fluorescence intensity was moderately de-
creased with normoxic PM or MSC treatment but remarkably
attenuated by hypoxic PM treatment (Fig. 3C). Total amount
of Cx43 decreased in the sham-injected area and moderately
decreased by the normoxic PM–treated border zone, but
increased in the hypoxic PM–treated border zone (Fig. 3D).
Hypoxic PM modulates Ca2-regulatory ion channels
nd proteins. Alteration of Ca2-regulatory ion channels
Figure 2 Peri-Infarct Zone as Arrhythmogenic Substrate and R
(A) The isochronal map (left) shows a focal discharge at the peri-infarct zone. The
der zone (right) shows that the focal beats emanating from the border (*) initiate
cate the paced beats. (B) Local conduction velocities (CV). There is a more than 5
border zone (*p  0.001, Mann-Whitney U test for independent samples). (C) Re
(white circle) (78 m  78 m). CV within the infarct region was largely elevated
and MSC-engrafted zone (sites 1 and 2, respectively, in left panel), real heart ima
(middle), and 4=,6-diamidino-2-phenylindole (DAPI)-coated MSCs (right). The black
the MSC-injected site. Immunohistostaining identifies the presence of DAPI-coated
abbreviations as in Figure 1.nd proteins in the border zone contribute to triggering nasily focal activity and may affect electrical conduction
16,17). We observed a marked decrease in messenger
ibonucleic acid (mRNA) levels of L-type calcium channel
LTCC), sarcoplasmic/endoplasmic reticulum calcium adeno-
ine triphosphatase 2a, Na/K adenosine triphosphatase, and
the calcium-binding proteins, calreticulin and calmodulin in
the border zone, which was significantly restored in hypoxic
PM–treated area and moderately in normoxic PM–treated area
(Fig. 4A). The increased mRNA level of the Na/Ca2
exchanger in the border zone, of which increased activity lead
to delayed afterdepolarization, was completely rescued by
hypoxic PM and partially by normoxic PM (Fig. 4A). We did
not assess the alteration of Ca2-regulatory ion channels and
roteins in MSC-transplanted border zone, because ion chan-
ation of Conduction by Hypoxic PM
bar indicates local activation times. The action potential recorded from the bor-
ed arrows indicate the direction of wave front propagation. Black triangles indi-
ncrease within the hypoxic PM–injected border zone versus the sham-injected
tative examples of CV maps in hypoxic PM– and normoxic PM–treated region
oxic PM–injected heart. (D) The action potential recorded in the normal zone
h a representative isochronal map during pacing in the MSC-engrafted heart
s indicate the optical view fields with 10 mm  10 mm. The red circle indicates
around the injected lesion (right). LV  left ventricle; RV  right ventricle; otherestor
scale
VT. R
-fold i
presen
in hyp
ge wit
boxe
MSCels of MSC are known to be different (18).
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October 23, 2012:1698–706 Antiarrhythmic Potential of Paracrine FactorsDifferent action of hypoxic PM and normoxic PM
in vitro study. For the in vitro study, cardiomyocytes (2 
106) were subjected to 3 h of hypoxia followed by reperfu-
sion and treatment of hypoxic or normoxic PM. We also
evaluated survival and change of Cx43 and dephosphory-
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Figure 3 Histological Analysis and Effects of PM or MSC on Cx
(A) Deoxyuride-5=-triphosphate biotin nick end labeling (TUNEL) assay for apoptotic
injected hearts versus sham-injected hearts (*p  0.01, **p  0.001). (B) Mass
decreased in hypoxic PM–treated hearts and not noticeably decreased in normoxic
for connexin 43 (Cx43). In sham-injected hearts, total Cx43 signal (green) decrea
increased. Hypoxic PM ameliorated dramatically the distribution of total Cx43 and
tially restored by normoxic PM or MSC injection (*p  0.001 vs. sham, †p  0.01
increase of Cx43 expression by hypoxic PM in border zone of infarcted heart waslated Cx43 in ischemic cardiomyocytes with no treatment,treated by hypoxic or normoxic PM, which was consistent
with the in vivo study results (Online Figs. 6 and 7).
Next, alterations in impaired intracellular calcium were
examined, because focal activity is easily induced by Ca2
overload in an ischemic setting. A significant increase in
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. TUNEL-positive myocardial cells were significantly reduced in hypoxic PM–
hrome staining for determination of fibrosis area. Fibrosis was significantly
or MSC-injected hearts (*p  0.01, **p  0.001). (C) Immunohistochemistry
d its array was disturbed, whereas dephosphorylated Cx43 signal (red)
ated dephosphorylated Cx43 signal, whereas the disarray of total Cx43 was par-
ham, ‡p  0.05 vs. hypoxic PM). (D) Western blot analysis for Cx43. The
(**p  0.001). AU  arbitrary units; other abbreviations as in Figures 1 and 2.B
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Antiarrhythmic Potential of Paracrine Factors October 23, 2012:1698–706indicating Ca2 overload. However, hypoxic PM decreased
the fluorescence intensity by 65% compared with that for
control subjects and produced a 2-fold decrease compared
with that in subjects treated with normoxic PM (Fig. 4B).
In addition, we observed mRNA expression levels of LTCC,
sarcoplasmic/endoplasmic reticulum calcium adenosine
triphosphatase 2a, Na/K adenosine triphosphatase, calreti-
ulin, calmodulin, and Na/Ca2 exchanger, which were
consistent with those in the in vivo study (Online Fig. 8).
Different expression of paracrine factors secreted under
hypoxic and normoxic environment. We then performed
proteomic analysis to identify the paracrine factors that were
responsible for the differences between hypoxic PM and
normoxic PM. As shown in Online Table 3, the secreted
levels of the growth factors basic fibroblast growth factor
(bFGF), insulin-like growth factor (IGF)-1, and hepatocyte
growth factor (HGF) differed between hypoxic PM and
Na+/K+ ATPase
Na+/Ca2+ exchanger 
SERCA2a
Calreticulin
Calmodulin
LTCC
GAPDH
Border zone
Fo
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ng
e
0
3
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B
NormoHypoxic PMControl
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Figure 4 Alteration of Ca2-Regulatory Proteins and Intracellul
(A) Effect of paracrine media (PM) on genes coding for ion exchangers and Ca2-r
(NCX), sarcoplasmic/endoplasmic reticulum calcium adenosine triphosphatase SE
calreticulin, and calmodulin in sham-, hypoxic PM–, normoxic PM–injected border z
**p  0.001). (B) Representative fluorescent images of cytosolic free Ca2 and
cardiomyocytes (*p  0.01, **p  0.001). GAPDH  glyceraldehyde-3-phosphatenormoxic PM. We found that bFGF, which stimulatesCx43 (19), regulates intracellular Ca2 and is related to
antiapoptosis (20), which was 8-fold higher in hypoxic PM
than in normoxic PM (Online Figs. 7 and 8). The level of
IGF-1, which has been shown to be related to Cx43
expression (21), and HGF, antifibrotic and antiapoptotic
factor (22,23) were elevated in hypoxic PM versus normoxic
PM (Online Figs. 7 and 8). Moreover, EF-hand domain-
containing 2, reticulocalbin 2, secreted modular calcium-
binding protein 1, and secretogranin II, which are known to
regulate calcium homeostasis (24–27), were detected only in
hypoxic PM (Online Table 3).
Discussion
The current study demonstrated that: 1) paracrine factors
from MSC depend on the surrounding conditions, specifi-
cally whether it is under hypoxic or normoxic condition;
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October 23, 2012:1698–706 Antiarrhythmic Potential of Paracrine Factorsstrong antiarrhythmic effect and prevent sudden arrhythmic
death; and 3) their antiarrhythmic effect is attributable to
restoration of conduction and decreased ectopic focal activ-
ity, which are mediated by suppression of fibrotic response,
recovery of gap junctions and calcium-regulatory proteins,
and alleviation of calcium overload. To the best of our
knowledge, this is the first experimental study to report on
the effect of paracrine factors on the antiarrhythmic poten-
tial of MSC and their potential impact on preventing
sudden deaths.
Stem cell therapies to cure MI have focused on differen-
tiating stem cells or engineering stem cells to behave like
cardiomyocytes. One of the major challenges facing stem
cell therapy is to create tissue heterogeneity, which may
potentially increase vulnerability to cardiac arrhythmias.
This study provides an alternative therapeutic approach
using paracrine factors, only released from the activated
MSC.
Fibrotic tissue surrounding surviving cells in infarcted
myocardium reduces the speed of impulse propagation,
blocks conduction, and facilitates reentry (9). Moreover,
fibrosis facilitates the ability to generate triggered activity by
a mechanism of sink-source mismatches through coupling
between cardiac myocytes and fibroblasts (28). This sequen-
tial process was weakened by paracrine growth factors or
cytokines from hypoxic MSC, such as bFGF and HGF,
thereby allowing a more synchronized electrical propagation
and contraction in hypoxic PM–treated hearts. Even though
reduced fibrosis and cell death may lead to improvement of
contractile function and antiarrhythmic effect, the potency
of antiarrhythmic effect of paracrine molecules secreted from
MSC is likely to be more predominant (Online Fig. 3).
Disruption of Cx43 coupling is another main cause of
decreased CV in the border zone (15). We determined that
the levels of IGF and bFGF secreted from MSC were
significantly increased under hypoxia, and this was associ-
ated with increased Cx43 expression (19,21,29), leading to
enhanced conduction. Although the current study did not
demonstrate the direct association between IGF/bFGF and
Cx43 expression, bFGF and IGF were reported to increase
expression of Cx43 and suppress the ventricular arrhythmia
in another study (18). We also found that increased intra-
cellular Ca2 concentration was rescued with hypoxic PM.
An increase in Ca2 ions in the cell leads to an overload of
he sarcoplasmic reticulum, resulting in spontaneous Ca2
ions leakage from the sarcoplasmic reticulum. Reduction in
intracellular Ca2 by hypoxic PM (Fig. 4B) is in line with
eduction of PVC observed in the in vivo studies (Fig. 1C).
oreover, LTCC during decreased gap junction coupling
lays an increasing role in propagation (16,17). In our study,
recovery of LTCC by hypoxic PM may contribute to the
ncreased conduction at the border zone.
Despite the antiarrhythmic effects of paracrine factors
rom MSC, the inexcitability of MSC could be regarded as
roarrhythmogenic. However, it is difficult to evaluate the
irect proarrhythmic effect of cells transplanted into the dyocardium, independent of the paracrine effect released
rom injected MSC. It is assumed that MSC implanted
fter 1-h ligation of the left anterior descending coronary
rtery would be more likely under normoxic condition over
ime. It may be possible to deduce the cellular effect of MSC
n terms of arrhythmogenicity by comparing normoxic
M–treated rats and MSC-implanted rats. Our study dem-
nstrated that the degree of fibrosis, expression level of
x43 or Ca2-related proteins was not different in MSC-
nd normoxic PM–treated hearts, suggesting that MSC
mplanted at the border zone after ligation and release
ight release paracrine molecules similar to components of
ormoxic PM. The current study suggests that the cellular
roperties of MSC appear to be neither as beneficial, nor as
nfluential, for arrhythmogenicity as paracrine factors are.
he action potential of the MSC-injected region was longer
han that of the normoxic PM–injected site and similar to
he normal zone of the MSC-engrafted heart. Recently,
omputer simulation studies showed that myocytes can
ompensate for the additional electrical load of coupled
broblasts by increasing the sodium channel current, and a
eflow of this additional charge from fibroblasts to the
yocytes occurs during repolarization, consequently in-
reasing APDs (30,31). The MSC-myocyte coupling,
hich prolongs the myocyte refractory period, may facilitate
eentry by creating greater dispersion of repolarization.
evertheless, this study showed that there was no signifi-
ant difference in survival rate in MSC-engrafted rats versus
ormoxic PM–injected rats.
tudy limitations. Several study limitations are apparent.
irst, although we identified several growth factors (IGF,
FGF, and HGF) and Ca2 homeostasis-related proteins,
t is possible that other factors are involved. The focus of the
resent study was the role of environment surrounding stem
ells, rather than on the precise mechanism of paracrine
actors on arrhythmogenicity. Further studies are needed to
dentify major factors linking molecular mechanisms of
ntiarrhythmic effect from MSC. Second, the monitoring of
urvival was limited to a short period (11 days), not
ualifying as a long-term outcome of paracrine factors. This
tudy described ventricular arrhythmia occurring in the early
hase of MI, because a therapeutic strategy to target this
eriod is lacking (32), whereas the risk of sudden arrest or
eath is highest in the early phase of MI (12).
onclusions
ur study showed that in contrast to the negligible proar-
hythmic potential of MSC, paracrine molecules secreted
rom MSC had strong antiarrhythmic potential, depending
n their surrounding environment. It is likely that a hypoxic
r normoxic environment surrounding MSC affects the type
nd properties of the growth factors or cytokines, and these
ecreted molecules determine the characteristics of the
lectro-anatomical substrate of the surrounding myocar-
ium. Until now, previous studies have focused mainly on
1706 Hwang et al. JACC Vol. 60, No. 17, 2012
Antiarrhythmic Potential of Paracrine Factors October 23, 2012:1698–706cell types and delivery routes. However, our results demon-
strate that the environment of injected cells and their
dynamic interaction should also be considered and further
investigated to identify therapeutic potency and potential.
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APPENDIX
For expanded methods and supplemental figures and tables,
please see the online version of this paper.
